COMMUNIQUÉS West-GlobeNewswire

-
CVRx Announces Positive News on Outpatient Payment for Barostim
16/07/2025 -
Venus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025
16/07/2025 -
Jaya Biosciences Receives Patent Notices of Allowance in Japan, China, and Singapore for Novel Methods of Treating Neurological Diseases, including Alzheimer’s, Further Strengthening its Global Intellectual Property Portfolio
16/07/2025 -
Cognition Therapeutics' Positive Clinical Data from Zervimesine (CT1812) Phase 2 Study in Dementia with Lewy Bodies (DLB) will be Presented in a Podium Presentation at AAIC
16/07/2025 -
Qualigen Granted New Patents Covering 25 Countries
16/07/2025 -
MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30
16/07/2025 -
Vantive and Innovative Renal Care Enter into a Long-Term Agreement Focused on Enhanced Use of Technology to Expand Home Dialysis Therapies
16/07/2025 -
Cue Biopharma Reports New Complete Response and Confirmed 50% Overall Response Rate in Ongoing Phase 1 Trial of CUE-101 and Pembrolizumab in Recurrent/Metastatic HPV+ Head and Neck Cancer
16/07/2025 -
Madrigal Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra™ (Resmetirom)
16/07/2025 -
ViaDerma Announces Posting of Annual Report and Ongoing Evaluation of Public Status in Response to Market Changes
16/07/2025 -
La nouvelle science des superhumains : le système d’IA BioSport™ libère le potentiel caché des athlètes
16/07/2025 -
Communiqué de presse : Le SAR446597 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de l’atrophie géographique liée à la dégénérescence maculaire liée à l’âge
16/07/2025 -
Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration
16/07/2025 -
Evox Therapeutics Expands Scientific Advisory Board
16/07/2025 -
Barrett Family Foundation Makes Historic Gift to Help Build Extraordinary in Healthcare
16/07/2025 -
Jin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility
16/07/2025 -
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results
15/07/2025 -
Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025
15/07/2025 -
Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025
15/07/2025
Pages